TELZIR 50 mg/ml, oral suspension bottle, 225 ml
Active ingredients: FOSAMPRÉNAVIR, Fosamprenavir calcium
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 225 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TELZIR 50 mg/ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 225 ml avec fermeture de sécurité enfant avec seringue(s) doseuse(s) avec adaptateur(s) pour flacon
- Marketing authorisation holder
- VIIV HEALTHCARE UK (ROYAUME-UNI)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63544054CIP73640645CIP133400936406452Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FOSAMPRÉNAVIR CALCIQUEsuspension | 61 mg · 1 ml | SA |
| FOSAMPRÉNAVIRsuspension | 50 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.